financetom
Business
financetom
/
Business
/
Marjorie Taylor Greene to work with Musk's new government efficiency panel
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marjorie Taylor Greene to work with Musk's new government efficiency panel
Nov 21, 2024 6:52 PM

WASHINGTON, Nov 21 (Reuters) - Republican Marjorie

Taylor Greene said on Thursday she will chair a U.S. House of

Representatives panel on government efficiency, working with

billionaire Elon Musk and Vivek Ramaswamy in their effort to

streamline the U.S. government.

Musk, the billionaire CEO of Tesla and SpaceX, and

Ramaswamy, a former Republican presidential candidate and

biotech executive, were tasked by President-elect Donald Trump

with creating a panel of outside advisers to make

recommendations on how to reduce the size of federal workforce

and slash regulations.

Greene's government efficiency subcommittee was created by

House Oversight Committee chair James Comer to work with Musk

and Ramaswamy.

"I'm thrilled to announce I'll be chairing a brand new

subcommittee to work hand-in-hand with @ElonMusk and

@VivekGRamaswamy," Greene wrote on X.

Trump, Musk and Ramaswamy have touted ambitious claims

about the panel's ability to transform the U.S. government and

the effort has received widespread publicity and interest in how

it will operate.

But details have been sparse. On Wednesday, Musk and

Ramaswamy wrote an opinion piece saying they will use recent

U.S. Supreme Court rulings to take power away from federal

agencies and reduce regulations.

Trump has said the two will issue reports, and the new panel

said it wants to bring on "high IQ" staff and hold weekly

livestreams.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Novabay Pharmaceuticals Completes The Sale Of Its Eyecare Business To Prn
BRIEF-Novabay Pharmaceuticals Completes The Sale Of Its Eyecare Business To Prn
Jan 23, 2025
Jan 23 (Reuters) - NovaBay Pharmaceuticals Inc ( NBY ): * NOVABAY PHARMACEUTICALS COMPLETES THE SALE OF ITS EYECARE BUSINESS TO PRN AND FURTHER ADJOURNS ITS SPECIAL MEETING OF STOCKHOLDERS ON DISSOLUTION PROPOSAL Source text: Further company coverage: ...
Eloro Resources Reports Latest Drill Results From Iska Iska Project in Bolivia
Eloro Resources Reports Latest Drill Results From Iska Iska Project in Bolivia
Jan 23, 2025
08:12 AM EST, 01/23/2025 (MT Newswires) -- Eloro Resources ( ELRRF ) reported Thursday further assays from its definition diamond drilling program in the potential Santa Barbara starter pit area within the Iska Iska silver-tin polymetallic project in Bolivia. Results include 33 meters grading 1.39% tin within 87 meters grading 0.74% tin as the company opened up a major tin...
Lithium Argentina Up Pre-Market After Completing Move to Switzerland
Lithium Argentina Up Pre-Market After Completing Move to Switzerland
Jan 23, 2025
08:16 AM EST, 01/23/2025 (MT Newswires) -- Lithium Argentina AG (formerly Lithium Americas (Argentina) ( LAAC ) with tickers LAAC.TO and NYSE: LAAC) up was about 2% in U.S. pre-market on Thursday after the company completed the previously announced plan to move its corporate domicile to Switzerland from Canada. The company will continue to list its common shares on the...
Freeport-McMoRan Q4 Adjusted Earnings Rise, Revenue Falls
Freeport-McMoRan Q4 Adjusted Earnings Rise, Revenue Falls
Jan 23, 2025
08:10 AM EST, 01/23/2025 (MT Newswires) -- Freeport-McMoRan ( FCX ) reported Q4 adjusted earnings Thursday of $0.31 per share, up from $0.27 a year earlier. Analysts polled by FactSet expected $0.22. Revenue for the quarter ended Dec. 31 was $5.72 billion, compared with $5.91 billion a year earlier. Analysts surveyed by FactSet expected $5.84 billion. Freeport-McMoRan ( FCX )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved